Lawrence P. Guiheen, Director at ADMA BIOLOGICS, INC. (ADMA), bought 20,000 shares at $3.50 ($70K) on 2020-02-11, disclosed to the SEC on 2020-02-11.
Open-market purchase of $70k ADMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ADMA | SELL | 2024-09-11 | $166K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $100K | — | Filing → |
| ADMA | BUY | 2018-06-11 | $96K | — | Filing → |